As a result, nurses in primary care, endocrinology, emergency medicine, inpatient settings, ambulatory care, and telehealth are likely to encounter questions about medications that have not yet completed the traditional approval process
Maddison P, Ambrose PA, Sadalage G, Vincent A (2019) A prospective study of the incidence of myasthenia gravis in the East Midlands of England
Per the Ozempic prescribing information, treatment begins at 0.25 mg once weekly for 4 weeks (a tolerance-building step), then increases to 0.5 mg, with further increases to 1 mg and 2 mg as needed after at least 4 weeks on each level (FDA label)
This means that they can bypass the L-cells lower down in the gut and lead to lower GLP-1 release and greater hunger
The evidence base differs from FDA-approved products that have undergone extensive clinical trial review